THE USE OF DEXTRAN SULFATE HAVING AN AVERAGE MOLECULAR WEIGHT BELOW 10000 DA FOR INDUCING ANGIOGENISIS IN A SUBJECT

THE USE OF DEXTRAN SULFATE HAVING AN AVERAGE MOLECULAR WEIGHT BELOW 10000 DA FOR INDUCING ANGIOGENISIS IN A SUBJECT

The present embodiments relate to the use of dextran sulfate having an average molecular weight below 10 000 Da for inducing angiogenesis in a subject and for increasing blood flow in a subject suffering from ischemia.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WAAS, ANDERS, BRUCE, ADAM, BRUCE, LARS
Format: Patent
Sprache:eng ; pol
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present embodiments relate to the use of dextran sulfate having an average molecular weight below 10 000 Da for inducing angiogenesis in a subject and for increasing blood flow in a subject suffering from ischemia.